CURRICULUM VITAE

Name: Ahn, Taehoon, MD, Ph.D.,FSCAI, FACC

OfficeAddress: Division of Cardiology, HeartCenter,

Gachon University Gil Medical Center,

1198 Kuwol-dong, Namdong-ku, Incheon,

Korea 405-760

( Phone : +82-32-460-3054)

( Fax : +82-32-469-1906)

( e-mail : , )

Medical Education

1988 - 1991 Korea University

Seoul, Korea

Ph.D. in Medical Science

1986 - 1988 Korea University

Seoul, Korea

M.A. in Medical Science

1976 - 1982 Korea University

Seoul, Korea

Doctor of Medicine(M.D.)

Training

1998 – 1999 Research Fellow

Montreal Heart Institute

MontrealUniversity, Montreal, Canada

1997 - 1998 Interventional Fellow

Montreal Heart Institute

MontrealUniversity, Montreal, Canada

1989 - 1991 Clinical Fellow

Cardiology

KoreaUniversityHospital, Seoul, Korea

1986 - 1989 Residency

Internal Medicine

KoreaUniversityHospital, Seoul, Korea

1982 - 1983 Full Rotating Internship

KoreaUniversityHospital, Seoul, Korea

Hospital Appointments

2016.3-present Director, Cardiovascular Center, Gachon University Gil

Medical Center

2009.9 –2013.9 Director, Heart Center, Gil Hospital

2005.9-2009.8 Chief, Internal Medicine, Gachon University

2003.3 -2009.8 Chief, Cardiology Division of Internal Medicine

HeartCenter, GilMedicalCenter

Incheon, Korea

2001- Professor, GachonMedicalSchool

Heart Center, Gil Medical Center

Incheon, Korea

1999 -2001 Associate Professor, GachonMedicalSchool

Director, Cardiac Cath Laboratory,

HeartCenter, GilMedicalCenter

Incheon, Korea

1994 - 1997 Associate Director, Adult Cardiac CathLaboratory

Heart Center, Gil Medical Center

Incheon, Korea

1991- 1994 Staff Cardiologist

Department of Internal Medicine

GilMedicalCenter, Incheon, Korea

1983 - 1986 Military Physician

AeromedicalCenter, Air Force, Korea

Certificates and Licences

2011 Certification for Korean Society of Interventional Cardiology

(No; M1084)

1998 Certification for Interventional Fellowship (ICM)

1994 Korean Board Certification of Circulation

1994 Passed FMGEMS

1989 Korean Board Certification of Internal Medicine(No;2813)

1988 Medical Council of Canada Evaluating Examination

(MCCEE)

1982 Korean License of Medical Doctor(No;24455)

1982 Passed ECFMG

Professional Affiliations

2016.3 - Fellow, American College of Cardiology(FACC)

2014.4-2016.4 Chairman, Korean Society of Interventional Cardiology(KSIC)

2013.5-2014.3 President, Korean cardiovascular Complication Club(KCCC)

2011.3-2014.4 Director of special affairs, Korean Society of Interventional

Cardiology

2012.11-2014.11 Treasure, The Korean Society of Cardiology and The Korean

Cardiac Research Foundation

2008.12-2012.11President, Vascular Intervention Seminar(VIS) in Korea

2007-present Course Director, Endovascular and Coronary Intervention

in Seoul (ENCORESEOUL)

2002- Member, The Korean Society of Cardiac Angiography andInterventions

2000 – Fellow, The Society for Cardiac Angiography and Interventions(FSCAI)

1998 - Member, Canadian Circulation Society

1996 - Member, The Korean Society for Lipid andThrombosis

1995 - Member, The Korean Society of Atherosclerosis

1989 - Member, The Korean Society for Circulation

1989 - Member, The Korean Society for Internal Medicine

1981 - Member, Korean Society for Medical Science

Publications

저서

1. 심혈관중재매뉴얼 (2016), 발행인, 대한심혈관중재학회(ISBN: 978-89965763-3-4 93510)

2. VIS Manuel(2011), 발행인

3. KVIS Manuel (2016). 저자

3. 심혈관합병증 매뉴얼(2017), 저자

논문

1. Percutaneous mitral valvuloplasty by double balloon. Park JE, Choi IS, Ahn TH, Song TJ, Kim JW, Ro YM. Korean Circulation J 19:1,1989

2. Effects of verapamil and atenolol on the functional expansion following coronary occlusion and reperfusion in the open-chest dog. Ahn TH, Ro YM. J Korea Univ Med College, 28:211, 1991

3. In vivo delineation of regional myocardial perfusion in open-chest dog by hydrogen peroxide myocardial contrast echocardiography. Kim HK, Kim YH, Ahn TH, Seo HS, Ro YM. Korean J Circulation, 21:693, 1991

4. Effect of denopamine on left ventricular function in patients with chronic heart failure: Ahn TH, Kim YH, Jin DK, Seo HS, Shim WJ, Ro YM. Korean J Circulation, 21:940, 1991

5. The patterns of pulmonary venous flow in various heart diseases. Kim YH, Song WH, Ahn TH, Shim WJ, Ro YM. Korean J Circulation 21:311,1991

6. Serial changes of transmitral inflow patterns after acute myocardial infarction. Song WH, Kim YH, Lim DS, Kim HK, Ahn TH, Seo HS, Shim WJ, Ro YM. Korean J Circulation, 22:366 1992

7. High dose dipyridamole echocardiography in the diagnosis of coronary artery disease. Shim WJ, Seo HS, Ahn TH, Kim YH, Oh DJ, Park JE, Ro YM. Korean J Intern Med, 43:628, 1992

8. Experience in high-speed rotational coronary atherectomy (Rotablator). Shin EK, Ahn TH, Choi JW, Choi IS. Korean J Circulation 22:557,1992

9. Recanalization of chronic total occlusion of native coronary arteries by prolonged intracoronary urokinase infusion. Park YH, Choi JW, Ahn TH, Choi IS, Shin EK. Korean J Circulation 25:747,1995

10. Spontaneous coronary dissection. Son MS, Ahn TH, Shin EK. Korean J Circulation 26:137, 1995

11. Effect of preexcitation on Doppler Indexes of left ventricular filling in patients with Wolff-Parkinson-White Syndrome. Son MS, Ahn TH, Oh SJ, Son JW, Choi IS, Shin EK, Lee SJ. Korean J Circulation 27:965,1997

12. Initial results after implantation of coronary artery stents with antiplatelet agents. Son JW, Kim YJ, Son MS, Oh SJ, Ahn TH, Choi IS, Shin IK. Korean J Circulation 28:939,

1998

13. Immediate and long -term outcome of single, long stent for long complex coronary artery stenosis compared to multiple conventional stents. Jin D, Lee Y, Lee H, Jung W, Kim Y, Oh S, Son M, Son J, Ahn T, Choi I, Shin E. Korean J Circulation 28:1465, 1998

14. Newer Antiplatelet Agents. Ahn T. The Korean Society of Lipidology 9:376, 1999

15. Influence of stent expansion states on platelet deposition in an extracorporeal porcine arteriovenous shunt model using a multichannel perfusion channel. Ahn T, Shin E, Merhi Y, Thai P, Bilodeau L. J Korean Med Sci 16:31, 2001

16. Efficacy of heparin-coated stent in early setting of acute myocardial infarction. Shin E, Son J, Dohn M, Jin D, Park G, Koh K, Ahn T, Choi I. Cathet Cardiovasc Intervent 52:306, 2001

17. Long-term outcomes of primary stenting in acute myocardial infarction. Son MS, Son JW, Park KS, Jin DK, Ahn TH, Koh KK, Choi IS, Shin EK, Dh SJ. Korean Circulation J 2002;31;742-748

18. Clinical experience of cutting balloon angioplasty for in-stent restenosis. Park KS, Ahn TH, Son MS, Shon JW, Ryu ES, Jin DK, Koh KK, Choi IS, Shin EK. Korean Circulation J 2002; 32:317-321

19. The effects of platelet-derived growth factor inhibitor (Trapidil) on intimal hyperplasia following coronary stenting: Assessed by intravascular ultrasound. Ryu WS, Son MS, Son JW, Shin MS, Han SH, Park KS, Ahn TH, Koh KK, Choi IS, Shin EK. Korean Circulation J 2003;33(8):680-686

20. Comparative effects of diet and simvastatin on markers of thrombogenecity in patients with coronary artery disease. Koh KK, Son JW, Ahn JY, Kim DS, Han SH, Ahn TH, Choi IS, Park KS, Shin EK. Am J Cardiol 2003;91:1231-1234

21. Pleiotropic effects of angiotensin II receptor blocker in hypertension patients. Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, Kim HS, Shin MS, Ahn TH, Choi IS, Shin EK. J Am Coll Cardiol 2003;42:905-10

22. Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia. Koh KK, Ahn JY, Jin DK Han SS, Kim HS, Choi IS, Ahn TH, Shin EK, Jeong EM. International J of Cardiology 2004: 97;239-244

23. The Effect and Tolerability of Lercanidipine in Elderly Hypertension Patients. Ahn TH. Medical Progress. October, 2004

24. Comparison of effects of Losartan, Irbesartan, and Candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension. Koh KK, Han SH, Chung WJ, Ahn JY, Jin DK, Kim HS, Park KS, Kang WC, AhnTH, Sin EK. Am J Cardiol 2004;93:1432-1435

25. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Koh KK, Quan MJ, Han SH, chung WJ, Ahn JY, Kang MH, Ahn TH, Choi IS, Shun EK. Circulation. 2004 Dec 14;110(24):3687-92.

26. The Long-Term clinical Outcomes of primary PTCA with Heparin-Coated Stent in Acute Myocardial Infarction. Kang WC, Han SS, Ahn TH, Son MS, Son JW Shin EK. The Korean Circulation J 2004;34:540-547

27. Successful management of a resistant, focal calcified lesion following direct coronary stenting with a cutting balloon. Kang WC, Ahn TH, Han SS, Shin EK. J Invasive cardiology 2004:16:725-726

28. Vascular effects of diet and statin in hypercholesterolemic patients. Koh KK, Son JW, Ahn JY, Jin DK, Kim HS, Choi YM, Ahn TH, Kim DS, Shin EK. Int J Cardiol. 2004 Jun;95 (2-3):185-91.

29. Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study. Koh KK, Chung WJ, Ahn JY, Han SH, Kang WC, Seo YH, Ahn TH, Choi IS, Shun EK. Atherosclerosis. 2004 Nov;177(1):155-60.

30. Images in cardiovascular medicine. Severe pulmonary artery stenosis caused by extrinsic compression of a calcified circular ring. Kang WC, Park CH, Chung WJ, Han SH, Ahn TH, Shin EK. Circulation. 2005 Aug 9;112(6):e76-8.

31. Acute myocardial infarction caused by late stent thrombosis after deployment of a paclitaxel-eluting stent. Kang WC, Han SH, Choi KR, Ahn TH, Shin EK. J Invasive Cardiol. 2005 Jul;17(7):378-80.

32. Efficacy of thrombosuction using the Export aspiration catheter before primary percutaneous coronary intervention in acute myocardial infarction. Kang WC, Ahn TH, Han SH, Choi KR, Oh KJ, Chung WJ, Shin MS, Koh KK, Choi IS, Shin EK. Korean Circulation J 2005;35(2): 172-9

33. Successful percutaneous coronary intervention for severe stenosis of an anomalous left coronary artery originating from the proximal right coronary artery. Kang WC, Ahn TH, Shin EK. J Invasive Cardiol. 2006 May;18(5):E154-6.

34. Images in cardiovascular medicine. Implantation of a drug-eluting stent for the coronary artery stenosis of Takayasu arteritis: de novo and in-stent restenosis. Kang WC, Han SH, Oh KJ, AhnTH, Shin EK. Circulation 2006 May 2;113(17):e735-7.

35. Successful management of left main coronary artery stenosis with a paclitaxel-eluting stent in Takayasu's arteritis. Kang WC, Han SH, Ahn TH, Shin EK. Int J Cardiol. 2006 Mar 22;108(1):120-3.

36. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter randomized, double-blind, placebo-controlled, parallel-group, 8- week follow-up, noninferiority trial. Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kyun J, Yoon MH, Lim DS. Clin Ther 2006;28:537-51

37. The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study. Han SH, Ahn TH, Kang WC, Oh KJ, Chung WJ, Shin MS, Koh KK, Choi IS, Shin EK. Am Heart J. 2006 Nov;152(5):887.e1-7.

38. A rare case of anomalous left coronary artery from the pulmonary artery (ALCAPA) presenting congestive heart failure in an adult. Kang WC, Chung WJ, Choi CH, Park KY, Jeong MJ, Ahn TH, Shin EK. Int J Cardiol. 2007 Feb 7;115(2):e63-7.

39. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents. Kang WC, Oh KJ, Han SH, Ahn TH, Chung WJ, Shin MS, Koh KK, Choi IS, Shin EK. Int J Cardiol. 2007 Dec 15;123(1):12-7

40. Effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a polymer-based paclitaxel-eluting stent: angiographic and IVUS study. Kang WC, Oh KJ, Han SH, Ahn TH, Chung WJ, Shin MS, Koh KK, Choi IS, Shin EK. Int J Cardiol. 2007 Dec 15;123(1):50-4

41. Thrombosuction utilizing an export aspiration catheter during primary percutaneous coronary intervention in acute myocardial infarction. Kang WC, Ahn TH, Han SH, Chung WJ, Shin MS, Koh KK, Choi IS, Shin EK. Yonsei Med J. 2007 Apr 30;48(2):261-9

42. Acute myocardial infarction caused by rupture of minimal intrastent intimal hyperplasia after implantation of bare-metal stent. Kang WC, Han SH, Ahn TH, Shin EK.

Int J Cardiol. 2007 Aug 21;120(2):e37-40.

43. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS. Clin Ther. 2007 Nov;29(11):2365-73.

44. Progression of dissection due to residual dissection after intracoronary stenting for spontaneous coronary dissection at bifurcation site of LAD and diagonal artery. Kang WC, Oh KJ, Han SH, Ahn TH, Shin EK. Int J Cardiol. 2008 Apr 25;125(3):e40-3.

45. Simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stent and bare-metal stent. Kang WC, Moon CI, Ahn TH, Shin EK. Int J Cardiol. 2008 Jul 4;127(2):e89-92.

46. Identifying the course of a coronary-bronchial artery fistula using contrast-enhanced multi-detector row computed tomography. Kang WC, Moon C, Ahn TH, Shin EK. Int J Cardiol. 2008 Nov 28;130(3):e125-8.

47. Multiple stent strut fracture-induced restenosis in a diffuse long lesion treated with overlapping heterogeneous drug-eluting stent. Kang WC, Moon C 2nd, Ahn TH, Shin EK. Int J Cardiol. 2008 Oct 30;130(1):e30-3.

48. Rapidly growing angiosarcoma of the pericardium presenting as hemorrhagic pericardial effusion. Park SM, Kang WC, Park CH, Shin MS, Chung WJ, Ahn TH, Shin EK. Int J Cardiol. 2008 Oct 30;130(1):109-12.

49. Global Circumferential Strain by 2-Dimensional Speckle Tracking Method for the Evaluation of the Left Ventricular Function. Lee SI, Shin MS, Lee JS, Chung WJ, Shim EO, Kang WC, Moon CI, Ahn TH, Choi IS, Shin EK, Korean Circulation Journal Vol.38,No.7 July, 2008

50. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial. Ahn Y, Jeong MH, Jeong JW, Kim KH, Ahn TH, Kang WC, Park CG, Kim JH, Chae IH, Nam CW, Hur SH, Bae JH, Kim KY, Oh SK. Circ J. 2008 Jan;72(1):35-9.

51. Stents versus coronary-artery bypass grafting for left main coronary artery disease. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. N Engl J Med. 2008 Apr 24;358(17):1781-92.

52. Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial. Kim SA, Park S, Chung N, Lim DS, Yang JY, Oh BH, Tahk SJ, Ahn TH. Clin Ther. 2008 May;30(5):845-57.

53. Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]). Kim JS, Moon JY, Ko YG, Choi D, Jang Y, Kang WC, Ahn T, Kim BK, Oh SJ, Jeon DW, Yang JY. Am J Cardiol. 2008 Aug 1;102(3):304-10. Epub 2008 May 14.

54. Stents versus coronary-artery bypass grafting for left main coronary artery disease. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. N Engl J Med. 2008 Apr 24;358(17):1781-92.

55. Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents. Kang WC, Ahn TH, Moon CI, Han SH, Shin EK, Kim JS, Ko YG, Choi D, Jang Y, Kim BK, Oh SJ, Jeon DW, Yang JY. Heart. 2009 Jun;95(12):970-5.

56. Pseudo-no-reflow phenomenon in carotid artery stenting using FilterWire EX: successful recovery by aspiration thrombectomy. Han SH, Kang WC, Ahn TH, Shin EK. J Korean Med Sci. 2009 Oct;24(5):967-9

57. Echocardiographic assessments of left atrial strain and volume in healthy patients and patients with mitral valvular heart disease by tissue Doppler imaging and 3-dimensional echocardiography. Shin MS, Kim BR, Oh KJ, Bong JM, Chung WJ, Kang WC, Han SH, Moon CI, Ahn TH, Choi IS, Shin EK. Korean Circ J. 2009 Jul;39(7):280-7

58. Clinical significance of left ventricular torsional parameters during supine bicycle cardiopulmonary exercise echocardiography. Choo SE, Chung WJ, Jang JW, BS, Bong JM, Shin MS, Koh KK, Ahn TH, Choi IS, Shin EK. Journal of Cardiovascular Ultrasound 2009 March Vol.17, No.1

59. Inferior sinus venosus type atrial septal defect initially presenting pulmonary hypertension on transthoracic echocardiography. Cho HJ, Chung WJ, Bong JM, Shin WC, Shin MS, Kang WC, Han SH, Moon CI, Koh KK, Ahn TH, Choi IS, Shin EK. Journal of Cardiovascular Ultrasound 2009 March Vol.17, No.1

60. Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker on Fibrinolysis and Left Ventricular Diastolic Function in Patients with Metabolic Syndrome. Shin MS, Kim BR, Chung WJ, Bong JM, Kang WC, Han SH, Moon CI, Ahn TH, Choi IS, Shin EK. Journal of The Korean Society of Hypertension 2009

61. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents(. Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators). Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, Park SW, Seung KB, Gwon HC, Jeong MH, Jang Y, Kim HS, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ; Circulation. 2009 Aug 4;120(5):400-7. Epub 2009 Jul 20.

62. Coronary Artery Perforation Following Implantation of a Drug-Eluting Stent Rescued by Deployment of a Covered Stent in Symptomatic Myocardial Bridging. Man Zhang, Kang WC, Moon CI, Han SH, Ahn TH, Shin EK, Korean Circ J. 2010 March; 40(3): 148–151.

63. Multidetector Computed Tomography for Evaluation of Ischemic Etiology and a Post-Unroofing Proccedure for an Anomalous Origin of the Right Coronary Artery From the Left Sinus of Valsalva. Man Zhang, , Woong Chol Kang, Tae Hoon Ahn, and Eak Kyun Shin, Korean Circ J. 2010 May; 40(5): 251–252.

64. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Li YJ, Rha SW, Chen KY, Poddar KL, Jin Z, Minami Y, Wang L, Dang Q, Li GP, Ramasamy S, Park JY, Choi CU, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Park JS, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim HS, Kim CJ, Yoon JH, Ahn TH, Tahk SJ, Chung WS, Seung KB, Park SJ; other Korea Acute Myocardial infarction Registry Investigators. Am Heart J. 2010 Apr;159(4):684-690.e1.

65. A Multicenter Eight-Week Treatment Single-Step Titration, Open-Label Study Assessing the Percentage of korean Dyslipidemic patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20mg and 40mg. Lee CW, Baek SH, Hong TJ, Choi YJ, Kim YJ, Ahn TH, Ihm SH, Bae JH, Hong SJ, Kim DI, Ahn YK, Hur SH, Park DG, Choi DJ, Lee SU, Kim BS, Ryu KH, Jang YS, Lee SH, Seung KB, Kim HS. Cardiovasc Drugs Ther. 2010 Apr;24(2):181-8.

66. Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea. Kim DH, Oh IY, Lee HY, Kim YJ, Kim HS, Kim CH, Oh BH, Kim KS, Kim DI, Kim YD, Ryu KH, Park SH, Baek SH, Shin DG, Shim WJ, Ahn TH, Oh SK, Lee SH, Lee SY, Jeong MH, Chung WS, Jeong JY, Choi SY, Choi SW, Hyon MS. Korean Circ J. 2010 Dec;40(12):632-8..

67. Real-Time 3-Dimensional Echocardiography of the Heart 13 Years After Partial Left Ventriculectomy. Shin MS, Ahn TH, Kim OR, Chung WJ, Kang WC, Lee KH, Moon CI, Choi IS, Shin EK, Lim CY. Korean Circ J. 2010 June; 40(6): 295–298.

68. Comparison of the effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a sirolimus- or paclitaxel-eluting stent. Kang WC, Ahn T, Moon CI, Lee K, Han SH, Shin EK, Kim JS, Ko YG, Choi D, Jang Y, Kim BK, Oh SJ, Jeon DW, Yang JY. Cardiology. 2010 Jul;116(2):117-22

69. Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry. Park DW, Seung KB, Kim YH, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Gwon HC, Jeong MH, Jang YS, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. J Am Coll Cardiol. 2010 Jul 6; 56(2):117-24.

70. Role of Stent. Ahn TH. CURRENT PRACTICE IN CARDIOLOGY 2010 Vol.4 (No.8) August.

71. Combined Open and Endovascular Repair for Aortic Arch Pathology. Kang WC, Shin EK, Ahn TH, Lee KH, Moon CI, Han SH, Park CH, Park KY, Kang JM, Kim JH. Korean Circ J. 2010 Aug; 40(8):399-404.

72. Impact of arterial remodeling on high sensitive C-reactive protein after a DES implantation Kang WC, Ahn TH, Moon CI, Han SH, Shin EK. Int J Cardiol. 2010 Nov 19; 145(2):325-6.

73. Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent. Kim BK, Ko YG, Oh S, Kim JS, Kang WC, Jeon DW, Yang JY, Choi D, Hong MK, Ahn T, Jang Y. Yonsei Med J. 2010 Nov 1; 51(6):823-31.